Related Experiment Videos
A Swedish family with abnormal antithrombin III
Scandinavian Journal of Haematology
|May 1, 1985
Summary
A novel abnormal antithrombin III variant was identified in a young male experiencing deep vein thrombosis. This genetic mutation, inherited in an autosomal-dominant manner, impairs key clotting inhibition functions.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Deep vein thrombosis (DVT) is a serious condition often linked to clotting factor abnormalities.
- Antithrombin III (ATIII) is a crucial inhibitor of thrombin and Factor Xa, regulating blood coagulation.
- Deficiencies in ATIII increase the risk of thrombotic events.